FI971279A - Läkemedel - Google Patents

Läkemedel Download PDF

Info

Publication number
FI971279A
FI971279A FI971279A FI971279A FI971279A FI 971279 A FI971279 A FI 971279A FI 971279 A FI971279 A FI 971279A FI 971279 A FI971279 A FI 971279A FI 971279 A FI971279 A FI 971279A
Authority
FI
Finland
Prior art keywords
drug
Prior art date
Application number
FI971279A
Other languages
English (en)
Finnish (fi)
Other versions
FI971279A0 (sv
Inventor
Li Li-Bovet
Keith Arthur Johnson
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Publication of FI971279A0 publication Critical patent/FI971279A0/sv
Publication of FI971279A publication Critical patent/FI971279A/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI971279A 1994-09-28 1997-03-26 Läkemedel FI971279A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9419536A GB9419536D0 (en) 1994-09-28 1994-09-28 Medicaments
PCT/IB1995/000866 WO1996009816A1 (en) 1994-09-28 1995-09-27 Medicaments

Publications (2)

Publication Number Publication Date
FI971279A0 FI971279A0 (sv) 1997-03-26
FI971279A true FI971279A (sv) 1997-03-26

Family

ID=10762008

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971279A FI971279A (sv) 1994-09-28 1997-03-26 Läkemedel

Country Status (32)

Country Link
US (1) US5849265A (sv)
EP (1) EP0783302B1 (sv)
JP (1) JPH10506887A (sv)
KR (1) KR100375469B1 (sv)
CN (1) CN1084614C (sv)
AP (1) AP742A (sv)
AT (1) ATE187063T1 (sv)
AU (1) AU707922B2 (sv)
BG (1) BG62839B1 (sv)
BR (1) BR9509108A (sv)
CZ (1) CZ286356B6 (sv)
DE (1) DE69513671T2 (sv)
DK (1) DK0783302T3 (sv)
EE (1) EE03380B1 (sv)
ES (1) ES2140706T3 (sv)
FI (1) FI971279A (sv)
GB (1) GB9419536D0 (sv)
GE (1) GEP20002140B (sv)
GR (1) GR3032245T3 (sv)
HU (1) HU221856B1 (sv)
IS (1) IS1991B (sv)
MD (1) MD1900C2 (sv)
MX (1) MX9702149A (sv)
NO (1) NO313658B1 (sv)
NZ (1) NZ292995A (sv)
OA (1) OA10603A (sv)
PL (1) PL181453B1 (sv)
RO (1) RO118564B1 (sv)
RU (1) RU2157188C2 (sv)
SK (1) SK281519B6 (sv)
UA (1) UA47412C2 (sv)
WO (1) WO1996009816A1 (sv)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9410222D0 (en) * 1994-05-21 1994-07-06 Glaxo Wellcome Australia Ltd Medicaments
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
US6984404B1 (en) 1998-11-18 2006-01-10 University Of Florida Research Foundation, Inc. Methods for preparing coated drug particles and pharmaceutical formulations thereof
JP2002541183A (ja) * 1999-04-14 2002-12-03 グラクソ グループ リミテッド 医薬用エアゾール製剤
US6406745B1 (en) * 1999-06-07 2002-06-18 Nanosphere, Inc. Methods for coating particles and particles produced thereby
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
US6451287B1 (en) 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
GB0016876D0 (en) * 2000-07-11 2000-08-30 Astrazeneca Ab Novel formulation
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
SK287576B6 (sk) * 2000-08-05 2011-03-04 Glaxo Group Limited S-fluórmetylester kyseliny 6alfa, 9alfa-difluór-17alfa-[(2- furanylkarboxyl)oxy]-11beta-hydroxy-16alfa-metyl-3-oxo-androsta- 1,4-dién-17beta-karbotiovej, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom, jeho použitie a medziprodukty
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US7217409B2 (en) 2000-09-22 2007-05-15 Smithkline Beecham Corporation Alkanoic acid derivatives
GB0106046D0 (en) 2001-03-12 2001-05-02 Glaxo Group Ltd Canister
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
AR033290A1 (es) * 2001-04-30 2003-12-10 Glaxo Group Ltd Derivados antiinflamatorios de androstano
WO2002100879A1 (en) * 2001-06-12 2002-12-19 Glaxo Group Limited Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives
GB0118364D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Compounds
WO2003013610A2 (en) * 2001-08-03 2003-02-20 Glaxo Group Limited Surfactant compounds and uses thereof
GB0125127D0 (en) 2001-10-19 2001-12-12 Glaxo Group Ltd Compounds
US6702997B2 (en) 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US20030203930A1 (en) * 2001-10-26 2003-10-30 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20030140920A1 (en) * 2001-10-26 2003-07-31 Dey L.P. Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
JP2003221335A (ja) 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20030191151A1 (en) * 2001-10-26 2003-10-09 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
US7217833B2 (en) * 2002-02-13 2007-05-15 Glaxco Group Limited Carboxylic acid compounds for use as surfactants
GB0205327D0 (en) * 2002-03-06 2002-04-17 Glaxo Group Ltd compounds
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1654312B1 (en) 2003-08-11 2014-01-15 Glaxo Group Limited Pharmaceutical metered dose inhaler and methods relating thereto
JP5053635B2 (ja) 2003-08-29 2012-10-17 グラクソ グループ リミテッド 医療用定量噴霧式吸入器及びそれに関連する方法
US7030255B2 (en) * 2004-03-09 2006-04-18 Lyondell Chemical Technology, L.P. Oxidation process with in-situ H202 generation and polymer-encapsulated catalysts therefor
EP1811981B1 (en) * 2004-10-12 2008-08-13 Merck Generics (UK) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
EP1949891A1 (en) 2004-10-12 2008-07-30 Generics (UK) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
EP2425820B1 (en) 2007-02-11 2015-04-08 MAP Pharmaceuticals Inc Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
GB0712454D0 (en) * 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
CA2059288C (en) * 1989-06-22 2001-02-13 Jean Riess Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
AU654813B2 (en) * 1990-03-23 1994-11-24 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
WO1992000062A1 (en) * 1990-06-27 1992-01-09 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
US5126123A (en) * 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations

Also Published As

Publication number Publication date
JPH10506887A (ja) 1998-07-07
CZ286356B6 (cs) 2000-03-15
IS4438A (is) 1997-03-10
MX9702149A (es) 1998-04-30
MD1900C2 (ro) 2002-12-31
GEP20002140B (en) 2000-06-25
MD970134A (en) 1999-02-28
EE03380B1 (et) 2001-04-16
HUT77377A (hu) 1998-04-28
SK39397A3 (en) 1997-10-08
CN1168630A (zh) 1997-12-24
HU221856B1 (hu) 2003-02-28
DE69513671D1 (de) 2000-01-05
DE69513671T2 (de) 2000-04-06
US5849265A (en) 1998-12-15
AU3532195A (en) 1996-04-19
AP9700951A0 (en) 1997-04-30
MD1900B2 (en) 2002-04-30
CN1084614C (zh) 2002-05-15
NO971422L (no) 1997-05-23
OA10603A (en) 2002-08-30
GR3032245T3 (en) 2000-04-27
AU707922B2 (en) 1999-07-22
ATE187063T1 (de) 1999-12-15
EP0783302B1 (en) 1999-12-01
KR970705981A (ko) 1997-11-03
UA47412C2 (uk) 2002-07-15
PL319342A1 (en) 1997-08-04
EE9700061A (et) 1997-08-15
FI971279A0 (sv) 1997-03-26
BR9509108A (pt) 1998-07-14
WO1996009816A1 (en) 1996-04-04
AP742A (en) 1999-04-26
NO971422D0 (no) 1997-03-25
RU2157188C2 (ru) 2000-10-10
CZ93697A3 (en) 1997-08-13
KR100375469B1 (ko) 2003-10-17
SK281519B6 (sk) 2001-04-09
BG101347A (en) 1997-12-30
DK0783302T3 (da) 2000-05-29
IS1991B (is) 2005-02-15
ES2140706T3 (es) 2000-03-01
NZ292995A (en) 1998-10-28
NO313658B1 (no) 2002-11-11
RO118564B1 (ro) 2003-07-30
PL181453B1 (pl) 2001-07-31
GB9419536D0 (en) 1994-11-16
EP0783302A1 (en) 1997-07-16
BG62839B1 (bg) 2000-09-29

Similar Documents

Publication Publication Date Title
FI971279A (sv) Läkemedel
NO964106D0 (no) Spröyte
ID23874A (id) Obat
DE69510024T2 (de) Spritze
DK1017392T3 (da) Lægemiddel
BR9600809A (pt) Medicamento
BR9508339A (pt) Medicamento
FI955605A0 (sv) Arylerande läkemedel
FI951155A0 (sv) Farmaceutiskt preparat
FI971369A0 (sv) Centralantennavtappare
NO944330D0 (no) Legemiddel
SE9401674L (sv) Läkemedel
SE9402131D0 (sv) Läkemedel
KR950022733U (ko) 세척기
DE9405878U1 (de) Rhenchodepressive Substanz
FIU940491U0 (fi) Avstaengningsspjaell
NO962816D0 (no) Farmasöytiske forbindelser
UA25523A (uk) Лікувальhий препарат гірчичhик
SE9404467D0 (sv) Drug formulations
NO933315D0 (no) Legemiddel
KR960016384U (ko) 주사기
KR950026744U (ko) 주사기
DE9412138U1 (de) Beruhigungs-Sauger
KR970000373U (ko) 세척기
KR960036267U (ko) 세척기

Legal Events

Date Code Title Description
FD Application lapsed